Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Minor depressive disorder and subsyndromal depressive symptoms: functional impairment and response to treatment

Rapaport, M · 1998 · Journal of Affective Disorders

Abstract

Background This study quantifies functional impairment and depressive symptomatology in patients with minor depressive disorder (MinD) and subsyndromal depressive symptomatology (SSD) before and after 8 weeks of treatment with fluvoxamine. Study patients were compared and contrasted with archival data from a sample of the general population measured by the Medical Outcome Survey Short Form 36. Method Fifteen patients with MinD and 15 patients with SSD were identified from primary care clinics, referrals and newspaper advertisements. Patients signed informed consent and were offered open label treatment with fluvoxamine 25-100 mg/day. Patients were seen biweekly and measures of functional impairment and depressive symptomatology were gathered systematically. Results MinD and SSD were associated with dysfunction and disability when compared to archival normative data from the general population. Eight week treatment with fluvoxamine was associated with a substantial decrease in depressive symptomatology and a normalization of psychosocial functioning. Conclusion This is the first study to quantify functional impairment and the severity of depressive symptomatology in a clinical sample of patients with MinD and SSD, and to demonstrate that treatment with a selective serotonin reuptake inhibitor decreases depressive symptomatology and improves psychosocial functioning. Placebo-controlled double-blind confirmation of these preliminary observations seems warranted.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0165-0327(97)00196-1

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 13 references

Cited by

See all 164

Metadata

Authors
Rapaport, M.
Affiliations
Veterans Health Administration (US)
Corresponding author
Rapaport, M
Venue
Journal of Affective Disorders
Publisher
Elsevier BV
Published
1998-03-01
Volume
48
Issue
2-3
Pages
227-232
ISSN
0165-0327 (ISSN-L)
OpenAlex
W1979556598
Cited by
163
References
13
Citations by year
2025: 2 · 2024: 1 · 2023: 1 · 2021: 3 · 2020: 3 · 2019: 4 · 2018: 4 · 2017: 1 · 2016: 6 · 2015: 8 · 2014: 4 · 2013: 11 · 2012: 7
FWCI
4.93
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Journal of Affective Disorders (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Mental Health (R29MH049746, MH49746-01, MH30914-20)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
Keywords
minor depressive disorder, subsyndromal depressive symptoms, functional disability, depression severity, fluvoxamine, selective serotonin reuptake inhibitors, psychosocial functioning, disability, treatment response
MeSH terms
Depression, Depressive Disorder, Female, Follow-Up Studies, Humans, Male, Middle Aged, Pilot Projects, Quality of Life, Severity of Illness Index, Social Adjustment, Fluvoxamine, Treatment Outcome, Cost of Illness, Selective Serotonin Reuptake Inhibitors, Antidepressive Agents, Second-Generation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Minor depressive disorder and subsyndromal depressive symptoms: functional impairment and response to treatment. https://app.cochat.ai/papers/10.1016/s0165-0327(97)00196-1
The paper
Rapaport, M. (1998). Minor depressive disorder and subsyndromal depressive symptoms: functional impairment and response to treatment. Journal of Affective Disorders. https://doi.org/10.1016/s0165-0327(97)00196-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.